Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety
about
Retinopathy of prematurity: Past, present and futurePharmacologic interventions for the prevention and treatment of retinopathy of prematurityIGF-I in the clinics: Use in retinopathy of prematurityRetinopathy of prematurity: the need for prevention.The challenge of understanding cerebral white matter injury in the premature infant.Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.Nutrition, insulin-like growth factor-1 and retinopathy of prematurityDietary proteins and IGF I levels in preterm infants: determinants of growth, body composition, and neurodevelopment.IGF-1 in retinopathy of prematurity, a CNS neurovascular disease.Advances in understanding and management of retinopathy of prematurity.Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants.IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.Relationship between insulin-like growth factor 1, leptin and ghrelin levels and catch-up growth in small for gestational age infants of 27-31 weeks during neonatal intensive care unit admission.Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity.The progress of prophylactic treatment in retinopathy of prematurity.
P2860
Q26767012-FCFE03CE-6721-416D-A1BE-A05021B70571Q26772889-C369E464-8200-439D-9B34-B54DF7C7D306Q28070089-F9CA0FA1-328B-4749-AF2E-D7929C5DDAEAQ33585466-34F767FA-1B61-4858-961B-DE126DA47697Q34098352-0BC44F92-975B-43DC-8A04-D9889AF40A5CQ35950878-9B1ED157-2D1A-48BF-86DB-5F616DCF94E7Q37258163-B9F88283-0F17-4E7B-90B9-585335533BBFQ38261760-6F6B44C6-56C6-4439-AB2B-6F5202E42355Q38960055-B670050A-7F0A-4537-A505-B3E731334D65Q39052915-8CDEBD24-0642-4F6E-8351-3FB49512558CQ39167922-16362EAD-A6FF-4AD7-BD54-D91BC5DE0DD0Q47568034-2416CE55-5F67-4B1C-9A3E-E812CFA72CE0Q51548047-0A27510E-EAE3-4B02-9741-CFF397BEE289Q51746396-D0C040AA-9C2B-4423-92D7-F5870BED1B4CQ54999086-60F06BF3-841D-4AE6-A995-BC1A9026A87C
P2860
Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Longitudinal infusion of a com ...... kinetics and short-term safety
@ast
Longitudinal infusion of a com ...... kinetics and short-term safety
@en
type
label
Longitudinal infusion of a com ...... kinetics and short-term safety
@ast
Longitudinal infusion of a com ...... kinetics and short-term safety
@en
prefLabel
Longitudinal infusion of a com ...... kinetics and short-term safety
@ast
Longitudinal infusion of a com ...... kinetics and short-term safety
@en
P2093
P2860
P50
P356
P1433
P1476
Longitudinal infusion of a com ...... kinetics and short-term safety
@en
P2093
Aimon Niklasson
Anna-Lena Hård
Ingrid Hansen-Pupp
Lena E Friberg
Lois E H Smith
P2860
P2888
P356
10.1038/PR.2012.146
P407
P577
2012-10-24T00:00:00Z
P5875
P6179
1028382843